Half Year 2021 Nova Eye Medical Ltd Earnings Call Transcript
Thank you for standing by, and welcome to the Nova Eye Medical first half results presentation. (Operator Instructions)
I would now like to hand the conference over to Mr. Tom Spurling, Director. Please go ahead.
Good morning, everyone. Thanks for taking the time to listen to the story of our first half results. I have with me today Victor Previn in the room here in Kent Town in Adelaide in our office (inaudible) as well.
So we have the deck. If we could just -- we have the disclaimer, and then we fall through to our first slide on Page 3, discussion of our business. As all of you are aware, following the sale of business -- the Laser and Ultrasound business, our Nova Eye -- renamed Nova Eye business comprises 2 segments rather than 3, a glaucoma surgical devices business and a business in laser therapy for chronic age-related retinal conditions.
First on the glaucoma surgical devices segment. Glaucoma is the leading cause of blindness in the developed world.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |